Andrew Wood Selected Research

propan-2-yl 4- (6- (4- (2,5- difluorophenoxy)- 3- hydroxybut- 1- en- 1- yl)- 7- hydroxyoctahydro- 2H- cyclopenta(b)oxepin- 3- yl)butanoate

10/2016	Ocular Hypotensive Effect of ONO-9054, an EP3/FP Receptor Agonist: Results of a Randomized, Placebo-controlled, Dose Escalation Study.
6/2016	EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
12/2015	A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Wood Research Topics

Disease

11	Neoplasms (Cancer) 12/2023 - 10/2008
5	Ischemia 12/2023 - 08/2003
5	Neuroblastoma 04/2017 - 10/2008
5	Stroke (Strokes) 12/2009 - 04/2006
3	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2016 - 12/2015
3	Ocular Hypertension (Glaucoma, Suspect) 10/2016 - 12/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2007 - 04/2006
2	Solitary Kidney 12/2023 - 08/2023
2	Insulin Resistance 02/2023 - 01/2023
2	Huntington Disease (Huntington's Disease) 12/2022 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2015
2	Inflammation (Inflammations) 01/2018 - 08/2007
2	Alzheimer Disease (Alzheimer's Disease) 06/2013 - 04/2013
2	Ischemic Stroke 01/2009 - 01/2008
2	Leiomyoma (Uterine Fibroids) 10/2003 - 08/2003
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023
1	Non-Muscle Invasive Bladder Neoplasms 12/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	Diabetes Mellitus 10/2023
1	Chronic Renal Insufficiency 10/2023
1	Hypertension (High Blood Pressure) 10/2023
1	Necrosis 10/2023
1	Otitis Media with Effusion 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Corneal Injuries 10/2022
1	Fever (Fevers) 01/2022
1	Hand-Foot Syndrome 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Exanthema (Rash) 01/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022
1	Thoracoabdominal Aortic Aneurysm 07/2021
1	False Aneurysm (Pseudoaneurysm) 07/2021
1	Aneurysm (Aneurysms) 07/2021
1	Aortic Diseases 07/2021
1	Hyperhidrosis 01/2020
1	Pruritus (Itching) 01/2020
1	Cough 01/2020
1	Asthenia 01/2020
1	Disease Progression 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Genetic Risk Score 01/2018
1	Dental Caries (Decay, Dental) 01/2017
1	Infections 01/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2022 - 08/2003
4	CaspasesIBA 08/2007 - 08/2003
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2013
3	EnzymesIBA 01/2020 - 08/2003
3	propan-2-yl 4- (6- (4- (2,5- difluorophenoxy)- 3- hydroxybut- 1- en- 1- yl)- 7- hydroxyoctahydro- 2H- cyclopenta(b)oxepin- 3- yl)butanoateIBA 10/2016 - 12/2015
3	Caspase 3 (Caspase-3)IBA 11/2009 - 08/2003
2	Insulin (Novolin)FDA Link 10/2023 - 02/2023
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 01/2023
2	P-2 (P 2)IBA 02/2023 - 01/2023
2	Neurokinin-1 Receptor AntagonistsIBA 01/2020 - 01/2020
2	orvepitantIBA 01/2020 - 01/2020
2	AntibodiesIBA 01/2018 - 12/2016
2	Keratin-7 (Cytokeratin 7)IBA 01/2018 - 12/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2017 - 02/2013
2	prostaglandin F2alpha receptorIBA 06/2016 - 12/2015
2	ProstaglandinsIBA 06/2016 - 12/2015
2	Small Interfering RNA (siRNA)IBA 12/2015 - 04/2010
2	Amyloid (Amyloid Fibrils)IBA 06/2013 - 04/2013
2	Phosphotransferases (Kinase)IBA 02/2013 - 10/2008
2	GSK923295IBA 02/2013 - 04/2010
2	Anaplastic Lymphoma KinaseIBA 09/2009 - 10/2008
2	ImmunophilinsIBA 01/2008 - 07/2007
2	LigandsIBA 01/2008 - 07/2007
1	Interferon-alpha (Interferon Alfa)IBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 08/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	SteamIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2020
1	Substance PIBA 01/2020
1	Antitussive Agents (Antitussives)FDA Link 01/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	ribociclibIBA 04/2017
1	binimetinibIBA 04/2017
1	CollagenIBA 12/2016
1	Keratin-20 (Cytokeratin 20)IBA 12/2016
1	Keratins (Keratin)IBA 12/2016
1	Carcinoembryonic AntigenIBA 12/2016
1	Cadherins (E-Cadherin)IBA 12/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2016
1	Keratin-5 (Keratin 5)IBA 12/2016
1	Estrogen ReceptorsIBA 12/2016

Therapy/Procedure

13	Therapeutics 12/2023 - 03/2007
3	Nephrectomy 12/2023 - 08/2023
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2022
2	Stents 04/2015 - 04/2011
2	Uterine Artery Embolization 10/2003 - 08/2003
1	Warm Ischemia 12/2023
1	Cystectomy 12/2023
1	Transurethral Resection of Bladder 12/2023
1	Middle Ear Ventilation (Tympanostomy) 01/2023
1	Synchrotrons 10/2022
1	Endovascular Aneurysm Repair 07/2021
1	Drug Tapering 01/2020
1	Phytotherapy (Herbal Therapy) 01/2017